ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Revive Therapeutics Signs Exclusive Worldwide License Agreement For Medicinal Mushroom Ganoderma Lucidum To Treat Cancer
August 18, 2021Revive Therapeutics Ltd. ("Revive" or the "Company") is pleased to announce that Revive has entered into an exclusive license agreement (the "Agreement") with Puerto Rico Science Technology and Research Trust ("PRSTRT") -
Revive Therapeutics, UCSF partner to study Bucillamine for severe Covid-19
May 08, 2021Specialty life sciences company Revive Therapeutics has signed a research agreement with University of California, San Francisco (UCSF) to study Bucillamine as a potential treatment for severe Covid-19.
Pharma Sources Insight January 2025
